Clinical Trials on Guillain-Barré Syndrome in United States
Total 14289 results
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedMyelodysplastic SyndromesUnited States
-
Memorial Sloan Kettering Cancer CenterM.D. Anderson Cancer Center; Columbia University; Karyopharm Therapeutics IncCompletedMyelodysplastic SyndromesUnited States
-
Columbia UniversityCelgene CorporationActive, not recruiting
-
Onconova Therapeutics, Inc.Withdrawn
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)TerminatedMyelodysplastic SyndromesUnited States
-
Opsona Therapeutics Ltd.M.D. Anderson Cancer Center; Montefiore Medical Center; New York Presbyterian... and other collaboratorsCompletedMyelodysplastic SyndromeUnited States
-
M.D. Anderson Cancer CenterGenzyme, a Sanofi CompanyCompletedMyelodysplastic SyndromeUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedMyelodysplastic SyndromesUnited States
-
CelgeneCompletedMyelodysplastic SyndromeUnited States
-
Rush University Medical CenterH. Lundbeck A/STerminatedMyelodysplastic SyndromeUnited States
-
Arno TherapeuticsUnknown
-
Northwestern UniversityRobert H. Lurie Cancer CenterTerminatedMyelodysplastic SyndromesUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteGenentech, Inc.Completed
-
M.D. Anderson Cancer CenterCompletedMyelodysplastic SyndromeUnited States
-
Veeda OncologyCephalonTerminatedMyelodysplastic SyndromeUnited States
-
National Institutes of Health Clinical Center (CC)CompletedMyelodysplastic Syndromes | Hematologic DiseasesUnited States
-
Neurological Associates of West Los AngelesActive, not recruitingNeuralgia | Complex Regional Pain Syndromes | Thoracic Outlet Neurologic SyndromeUnited States
-
National Cancer Institute (NCI)RecruitingMyelodysplastic SyndromesUnited States
-
National Cancer Institute (NCI)Active, not recruiting
-
Gustavo RiveroBaylor College of MedicineTerminatedMyelodysplastic SyndromesUnited States
-
University of CincinnatiGenentech, Inc.WithdrawnMyelodysplastic SyndromeUnited States
-
Weill Medical College of Cornell UniversityCelgeneTerminatedMyelodysplastic SyndromeUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedMyelodysplastic SyndromesUnited States
-
M.D. Anderson Cancer CenterNovartis PharmaceuticalsTerminatedMyelodysplastic SyndromeUnited States
-
Weill Medical College of Cornell UniversityCTI BioPharmaCompletedMyelodysplastic SyndromeUnited States
-
Onconova Therapeutics, Inc.WithdrawnMyelodysplastic SyndromeUnited States
-
University of FloridaTeva Pharmaceutical Industries, Ltd.WithdrawnMyelodysplastic SyndromesUnited States
-
Virginia Commonwealth UniversityCelgene CorporationCompletedMyelodysplastic SyndromeUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteIncyte CorporationCompletedMyelodysplastic SyndromesUnited States
-
University of PittsburghCompletedMyelodysplastic SyndromesUnited States
-
The Vaccine CompanyUnknownMyelodysplastic SyndromesUnited States
-
Texas Oncology Cancer CenterGenzyme, a Sanofi CompanyTerminatedMyelodysplastic SyndromesUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)Completed
-
Masonic Cancer Center, University of MinnesotaRecruitingCommon Variable Immunodeficiency | Chronic Granulomatous Disease | Hemophagocytic Lymphohistiocytosis | Wiskott-Aldrich Syndrome | X-linked Lymphoproliferative Disease | Langerhan's Cell Histiocytosis | Chediak-Higashi Syndrome | Griscelli Syndrome | Bare Lymphocyte Syndrome | SCID | Omenn's Syndrome | Reticular... and other conditionsUnited States
-
AllerganCompletedDry Eye SyndromesUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingPreviously Treated Myelodysplastic Syndrome | Myelodysplastic Syndrome | Aplastic Anemia | de Novo Myelodysplastic SyndromeUnited States
-
Thomas Jefferson UniversityWithdrawnMyelodysplastic SyndromesUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI); Alliance for Cancer Gene TherapyTerminatedMyelodysplastic SyndromesUnited States
-
CelgeneCompletedMyelodysplastic SyndromeUnited States
-
University of FloridaGateway for Cancer Research; Cellworks Group Inc.WithdrawniCare 2: Personalized Genomic Mutation Informed Treatment of Patients With Myelodysplastic SyndromesMyelodysplastic SyndromesUnited States
-
Lixte Biotechnology Holdings, Inc.UnknownMyelodysplastic SyndromesUnited States
-
Weill Medical College of Cornell UniversitySunesis PharmaceuticalsCompletedVosaroxin for Intermediate 2 or High-risk MDS After Failure With Hypomethylating Agent-based TherapyMyelodysplastic SyndromeUnited States
-
Weill Medical College of Cornell UniversityCompletedMyelodysplastic SyndromeUnited States
-
Neal Young, M.D.CompletedMyelodysplastic SyndromeUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers SquibbCompletedMyelodysplastic SyndromesUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMyelodysplastic Syndrome | High Risk Myelodysplastic Syndrome | IPSS Risk Category Intermediate-1United States
-
National Institutes of Health Clinical Center (CC)CompletedMyelodysplastic Syndrome | 5q Minus SyndromeUnited States
-
Uma BorateRecruitingTherapy-Related Myelodysplastic Syndrome | Secondary Myelodysplastic SyndromeUnited States
-
Franziska WachterHarvard Clinical and Translational Science Center (Harvard Catalyst)RecruitingAcute Myeloid Leukemia | Myelodysplastic Syndromes | MDS | Aml | Myeloid Neoplasm | Myeloid Malignancies | Inherited Bone Marrow Failure SyndromeUnited States
-
Lindsey Russell, MDNapo Pharmaceuticals, Inc.Not yet recruitingShort Bowel SyndromeUnited States